# Program 1 Phase C126 - Acknowledgment Write Endpoint Final No-Go Review

Status: final no-go review

## Current Stack

Program 1 Phase C now has a guarded Human Review Acknowledgment stack:

- passive advisory signal schema and mapping contracts
- passive acknowledgment schemas
- acknowledgment DB foundation and constraints
- internal-only acknowledgment write service
- appointment-scoped read API
- read-only Appointment Workspace UI
- selective denied-read access audit
- CI and regression gates for no-write boundaries

This stack supports review visibility and access-security evidence. It does not support runtime acknowledgment writes through an endpoint or UI action.

## Surfaces Not Present

The following surfaces remain intentionally absent:

- POST/PATCH/PUT/DELETE acknowledgment endpoint
- frontend acknowledgment action button
- frontend acknowledgment write client
- acknowledgment write permission seed
- API key acknowledgment write permission
- AI/system-job acknowledgment write permission
- production approval
- real patient data approval

## Final C-Phase Decision

The acknowledgment write endpoint remains No-Go.

Adding a write endpoint now would create an unsafe semantic jump from "human reviewed advisory context" toward a workflow action users may interpret as resolution, readiness, or permission to proceed.

## Risk Basis

Write endpoint implementation remains blocked by:

- soft-clearance interpretation risk
- staff overreliance risk
- false reassurance risk
- legal and compliance ambiguity
- audit and retention review gaps
- UI pressure to add an action button
- incomplete Findings Lifecycle foundation
- unclear lifecycle for unresolved findings after acknowledgment

## Why D0 Is Safer

`Program 1 Phase D0 - Findings Lifecycle Foundation` is safer than an acknowledgment write endpoint because it defines the clinical units that need review before any human acknowledgment action can be treated responsibly.

Findings must have source links, status, review state, and lifecycle boundaries before acknowledgment writes are exposed. Otherwise acknowledgment can be mistaken for resolving clinical uncertainty.

## Safety Properties

C126 preserves:

- no clinical approval
- no readiness clearance
- no override workflow
- no Task engine
- no Outcome Evidence
- no appointment status mutation
- no patient messaging
- no production or real-data approval
- denied-read audit remains access/security evidence only

## Conclusion

Proceed to D0 rather than implementing an acknowledgment write endpoint.

